Home » Topics » BioWorld Science

BioWorld Science
RSS

Zealand Pharma divulges LPAM-1 antagonists

Jan. 27, 2022

Discovery of novel mGlu4 receptor PAMs with antipsychotic-like properties

Jan. 27, 2022

TRAF6 loss linked to development of myeloid malignancies

Jan. 27, 2022

Exon-skipping antisense oligonucleotides show promise for treating cystic fibrosis

Jan. 27, 2022

S2K146 protects against SARS-CoV-2 infection in preclinical models

Jan. 27, 2022

MAP-tau map of interactions shows more than microtubules

Jan. 26, 2022

Tumorad significantly reduces tumor growth and prolongs survival in colorectal cancer model

Jan. 26, 2022

Siga and Bioarchitech collaborate to study Tpoxx with vaccinia-based immunotherapy platform

Jan. 26, 2022

INmune Bio collaborates with CUHK to evaluate INKmune in nasopharyngeal cancer

Jan. 26, 2022

IMX-110 + anti-PD-1 extend median survival in genetic pancreatic cancer mouse model

Jan. 26, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...